+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Streptococcal Infection Drug"

Streptococcal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Streptococcal Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 60 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Streptococcal Infection Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat infections caused by Streptococcus bacteria, which can cause a range of illnesses from mild throat infections to life-threatening conditions such as meningitis. These drugs are typically antibiotics, which work by killing or inhibiting the growth of the bacteria. Commonly used antibiotics for Streptococcal infections include penicillin, amoxicillin, and cephalosporins. The Streptococcal Infection Drug market is highly competitive, with many large pharmaceutical companies offering a range of products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Show Less Read more